Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for integrating disease models, target genetics, multi omics, preclinical evidence, and curated public data to forecast therapeutic success prior to clinical investment; Artificial intelligence as a service (AIAAS) services featuring software using advanced artificial intelligence (AI) statistical models for calculating a drug success score to predict therapeutic progression from preclinical to approval using advanced AI statistical models.

'advanc':46,67 'ai':13,49,68 'aiaa':6,41 'approv':65 'artifici':1,11,36,47 'calcul':53 'clinic':34 'curat':25 'data':27 'diseas':16 'drug':55 'evid':23 'featur':8,43 'forecast':29 'genet':19 'integr':15 'intellig':2,12,37,48 'invest':35 'model':17,51,70 'multi':20 'omic':21 'preclin':22,63 'predict':59 'prior':32 'progress':61 'public':26 'score':57 'servic':5,7,40,42 'softwar':9,44 'statist':50,69 'success':31,56 'target':18 'therapeut':30,60 'use':10,45,66

DRUGSUCCESS.AI

Owners

Goods & Services